SLE

Immunology·MeSH: Lupus Erythematosus, Systemic

Prevalence

30.0 / 100K

75 drugs in development·57 companies·3 clinical trials

Drug Pipeline by Phase

Approved(24)

Drug	Company
Belsomra	Merck & Co., Inc. (MRK)
dextromethorphan polistirex	Amneal Pharmaceuticals, Inc. (AMRX)
edluar	Viatris Inc (VTRS)
gastrodin	CHINA PHARMA HOLDINGS, INC. (CPHI)
Gastrodin Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
guaifenesin	Amneal Pharmaceuticals, Inc. (AMRX)
guselkumab	Vor Biopharma Inc. (VOR)
hetlioz	Vanda Pharmaceuticals Inc. (VNDA)
ibuprofen	DR REDDYS LABORATORIES LTD (RDY)
ibuprofen	PERRIGO Co plc (PRGO)
inspire system	Inspire Medical Systems Inc. (INSP)
LUMRYZ	Alkermes plc. (ALKS)
naproxen	Amneal Pharmaceuticals, Inc. (AMRX)
pitolisant	Viatris Inc (VTRS)
pitolisant	Impax Laboratories, LLC (IPXL)
rest ez sleep aid supplement	REST EZ Inc. (RTEZ)
silenor	PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)
sodium oxybate	Nascent Biotech Inc. (NBIO)
Sunosi	Axsome Therapeutics, Inc. (AXSM)
venlafaxine	Teva Pharmaceutical Industries Limited (TEVA)
vyalev	AbbVie Inc. (ABBV)
WAKIX	Harmony Biosciences Holdings, Inc. (HRMY)
Zepbound	ELI LILLY & Co (LLY)
zolpidem	Teva Pharmaceutical Industries Limited (TEVA)

Phase 3(7)

Drug	Company
descartes-08	Cartesian Therapeutics, Inc. (RNAC)
Eloralintide	ELI LILLY & Co (LLY)
envudeucitinib	ALUMIS INC. (ALMS)
ESK-001	ALUMIS INC. (ALMS)
sar448501	Sanofi (SNYNF)
solriamfetol	Axsome Therapeutics, Inc. (AXSM)
WAKIX (pitolisant) - Prader-Willi Syndrome (PWS)	Harmony Biosciences Holdings, Inc. (HRMY)

Phase 2(13)

Drug	Company
AUCATZYL/obe-cel	Autolus Therapeutics plc (AUTL)
cfz533	Novartis AG (NVS)
danavorexton	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
danavorexton	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
iberdomide	CELGENE CORP /DE/ (CELG)
ihl-42x	Incannex Healthcare Inc. (IXHL)
imvotamab	IGM Biosciences, Inc. (IGMS)
lorundrostat	Mineralys Therapeutics, Inc. (MLYS)
mb-cart19.1	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
prv-3279	PROVENTION BIO, INC. (PBI)
PRV-3279	MACROGENICS INC (MGNX)
rese-cel	Cabaletta Bio, Inc. (CABA)
WAKIX (pitolisant) - Myotonic Dystrophy (DM1)	Harmony Biosciences Holdings, Inc. (HRMY)

Phase 1(14)

Drug	Company
apg-2575	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
cenerimod	Viatris Inc (VTRS)
CLN-978	Cullinan Therapeutics, Inc. (CGEM)
CTX112	CRISPR Therapeutics AG (CRSP)
Litifilimab	BIOGEN INC. (BIIB)
LUCAR-G79D T cells	Legend Biotech Corp (LEGN)
maridebart cafraglutide	AMGEN INC (AMGN)
pit565	Novartis AG (NVS)
pit565	Novartis AG (NVS)
prula-cel	Adicet Bio, Inc. (ACET)
pt101	Pandion Therapeutics, Inc. (PAND)
sar448501	Sanofi (SNY)
velinotamig	Cullinan Therapeutics, Inc. (CGEM)
vib7734	Viela Bio, Inc. (VIE)

Preclinical(8)

Drug	Company
eb201	Estrella Immunopharma Inc. (ESLA)
gelstat sleep	GELSTAT CORP (GSAC)
gri-0803	GRI Bio, Inc. (GRI)
inb-619	IN8BIO, INC. (INAB)
IRF5 program	ALUMIS INC. (ALMS)
melatonin	Aspire Biopharma Holdings Inc. (ASBP)
neurohub	BRAIN SCIENTIFIC INC. (BRSF)
prana bio nutrient medicinals	UNITED CANNABIS CORP (CNAB)

Unknown(6)

Drug	Company
iPScelz™ (iPSC program)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
PrimiSleep™	BIOADAPTIVES, INC. (BDPT)
Sky Premium Life (SPL)	Cosmos Health Inc. (COSM)
Sleep Well Gummies	Charlie's Holdings, Inc. (CHUC)
SleepEZ™	BIOADAPTIVES, INC. (BDPT)
SleepEZ™ (formerly PrimiSleep™)	BIOADAPTIVES, INC. (BDPT)

BLA Filed(1)

Drug	Company
apollo esg	Apollo Endosurgery, Inc. (APEN)

Phase 1/Phase 2(1)

Drug	Company
zugo-cel	CRISPR Therapeutics AG (CRSP)

Phase 4(1)

Drug	Company
bms-986165	BRISTOL MYERS SQUIBB CO (BMY)

BioSniper tracks 75 drugs in development for SLE across 57 companies.

There are 3 clinical trials targeting SLE tracked by BioSniper.

The estimated prevalence of SLE is approximately 30.0 per 100,000 population.

Full trial data, competitive analysis, and AI-powered pipeline tracking.